Overview
Winterlight Labs offers a tablet-based assessment leveraging speech analysis to detect cognitive impairment associated with dementia and mental illness. Their technology extracts speech-based digital biomarkers from short audio snippets, enabling objective and remote monitoring. The platform automates the review of clinical assessment administration and scoring. It supports life science partners throughout their clinical trials, offering assistance with site onboarding, data collection, speech analysis, and results interpretation. The core technology involves analyzing linguistic patterns, acoustic features, and semantic content within speech to identify subtle indicators of cognitive decline or psychiatric disorders. Winterlight's API allows integration with existing apps and devices that continuously collect speech data, providing fast analysis results. Trusted by leading life science companies, Winterlight's assessment is used to track disease progression and response to therapy in clinical research and senior care settings.